Patents by Inventor Clara Ross

Clara Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260049348
    Abstract: Disclosed herein are methods and compositions for normalizing polynucleotide concentration. Normalizing may be accomplished using polynucleotide binding proteins (e.g., catalytically inactive CRISPR protein or catalytically inactive Argonaute proteins). The polynucleotide binding proteins may bind to the adapter sequences of a target polynucleotide. Thus, adding the same amount of a polynucleotide binding proteins to different samples and then extracting the polynucleotide protein is shown herein to extract similar amounts of target polynucleotides from the different samples.
    Type: Application
    Filed: August 11, 2025
    Publication date: February 19, 2026
    Inventors: Martin Ranik, Eric van der Walt, Clara Ross, Craig Marshall, Lindsay Peterkin, Brian Kudlow, Travis J. Sanders
  • Patent number: 12410469
    Abstract: Disclosed herein are methods and compositions for normalizing polynucleotide concentration. Normalizing may be accomplished using polynucleotide binding proteins (e.g., catalytically inactive CRISPR protein or catalytically inactive Argonaute proteins). The polynucleotide binding proteins may bind to the adapter sequences of a target polynucleotide. Thus, adding the same amount of a polynucleotide binding proteins to different samples and then extracting the polynucleotide protein is shown herein to extract similar amounts of target polynucleotides from the different samples.
    Type: Grant
    Filed: October 23, 2023
    Date of Patent: September 9, 2025
    Assignee: Watchmaker Genomics, Inc.
    Inventors: Martin Ranik, Eric van der Walt, Clara Ross, Craig Marshall, Lindsay Peterkin, Brian Kudlow, Travis J. Sanders
  • Publication number: 20240229115
    Abstract: Disclosed herein are methods and compositions for normalizing polynucleotide concentration. Normalizing may be accomplished using polynucleotide binding proteins (e.g., catalytically inactive CRISPR protein or catalytically inactive Argonaute proteins). The polynucleotide binding proteins may bind to the adapter sequences of a target polynucleotide. Thus, adding the same amount of a polynucleotide binding proteins to different samples and then extracting the polynucleotide protein is shown herein to extract similar amounts of target polynucleotides from the different samples.
    Type: Application
    Filed: October 23, 2023
    Publication date: July 11, 2024
    Applicant: Watchmaker Genomics, Inc.
    Inventors: Martin Ranik, Eric van der Walt, Clara Ross, Craig Marshall, Lindsay Peterkin, Brian Kudlow
  • Publication number: 20240132942
    Abstract: Disclosed herein are methods and compositions for normalizing polynucleotide concentration. Normalizing may be accomplished using polynucleotide binding proteins (e.g., catalytically inactive CRISPR protein or catalytically inactive Argonaute proteins). The polynucleotide binding proteins may bind to the adapter sequences of a target polynucleotide. Thus, adding the same amount of a polynucleotide binding proteins to different samples and then extracting the polynucleotide protein is shown herein to extract similar amounts of target polynucleotides from the different samples.
    Type: Application
    Filed: October 22, 2023
    Publication date: April 25, 2024
    Applicant: Watchmaker Genomics, Inc.
    Inventors: Martin Ranik, Eric van der Walt, Clara Ross, Craig Marshall, Lindsay Peterkin, Brian Kudlow